TMCnet News

Research and Markets: Vancomycin-Resistant Enterococcus Faecium Infections - 2015 Pipeline Insights Report
[August 04, 2015]

Research and Markets: Vancomycin-Resistant Enterococcus Faecium Infections - 2015 Pipeline Insights Report


Research and Markets (http://www.researchandmarkets.com/research/bbg4gr/vancomycinresista) has announced the addition of the "Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights" report to their offering.

Vancomycin-Resistant Enterococcus Faecium Infections- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Vancomycin-Resistant Enterococcus Faecium Infections. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vancomycin-Resistant Enterococcus Faecium Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Vancomycin-Resistant Enterococcus Facium Infections- Pipeline Insights Report covers the Vancomycin-Resistant Enterococcus Faecium Infections pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Vancomycin-Resistant Enterococcus Faecium Infections related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Vancomycin-Resistant Enterococcus Faecium Infections.



Scope

- The report provides a Vancomycin-Resistant Enterococcus Faecium Infections Landscape across the globe


- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Vancomycin-Resistant Enterococcus Faecium Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Vancomycin-Resistant Enterococcus Faecium Infections and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/bbg4gr/vancomycinresista


[ Back To TMCnet.com's Homepage ]